Single Stage Biocartilage (Micronized Articular Cartilage) Kevin F. - - PowerPoint PPT Presentation

single stage biocartilage
SMART_READER_LITE
LIVE PREVIEW

Single Stage Biocartilage (Micronized Articular Cartilage) Kevin F. - - PowerPoint PPT Presentation

Advanced Practitioners Course: Dec 7, 2017 Single Stage Biocartilage (Micronized Articular Cartilage) Kevin F. Bonner MD Jordan-Young Institute; Virginia Beach, VA Assistant Professor, Eastern Virginia Medical School Kevin F Bonner MD


slide-1
SLIDE 1

Single Stage Biocartilage

(Micronized Articular Cartilage)

Kevin F. Bonner MD Jordan-Young Institute; Virginia Beach, VA Assistant Professor, Eastern Virginia Medical School Advanced Practitioners Course: Dec 7, 2017

slide-2
SLIDE 2

Kevin F Bonner MD Disclosures

1.Royalties : Zimmer / Biomet 2.Consulting : Smith & Nephew LifeNet Health Abyrx 3.Research and educational support : Depuy / Johnson & Johnson Zimmer / Biomet LifeNet Health

slide-3
SLIDE 3

Chondral Defects in the Knee:

Surgical Options

Lesion < 2 cm2 ? Primary Tx? Secondary Tx? Low Demand? High Demand? Low/High Demand

  • Arthrsocopic

Debridement

  • Marrow

Stimulating Technique (Microfracture, Abrasion, Drilling)

  • Arthrsocopic

Debridement

  • Marrow

Stimulating Technique (Microfracture, Abrasion, Drilling)

  • Osteochondral

Autograft

  • Autologous

Chondrocyte Implantation

  • Autologous

Chondrocyte Implantation

  • Osteochondral

Autograft

Lesion > 2 cm2 ? Primary Tx? Secondary Tx? Low Demand? High Demand? Low/High Demand

  • Autologous

Chondrocyte Implantation

  • Arthrsocopic

Debridement

  • Marrow

Stimulating Technique (Microfracture, Abrasion, Drilling)

  • Osteochondral

Autograft

  • Autologous

Chondrocyte Implantation

  • Osteochondral

Autograft

  • Autologous

Chondrocyte Implantation

  • Osteochondral

Allograft

  • Cole. Op Tech Orthopaedics 2001

Everyone develops their own personal, and likely ever-evolving, algorithm for cartilage defects

slide-4
SLIDE 4

Relative frequency of Cartilage Procedures 2003-2014

55 Million private insured pts Truven Health Marketscan Research Database

MFX to OAT 35:1 MFX to ACI 88:1

Khazai et al. AOSSM Toronto 2017

slide-5
SLIDE 5
slide-6
SLIDE 6

Debate: How best to perform marrow stimulation

  • Abrade vs perforate ?
  • Drill vs Impaction awls
  • Optimal Size & Depth?
  • Augmentation helpful?

Mithoefer et al. AJSM 2009

slide-7
SLIDE 7

Recent Reviews

  • Mithoefer K. Clinical efficacy of the microfracture technique for

articular cartilage repair in the knee. An evidence-based systematic

  • analysis. Am J Sports Med. 2009
  • Mithoefer K. Clinical Outcome and Return to Competition after

Microfracture in the Athlete's Knee: An Evidence-Based Systematic

  • Review. Cartilage. 2010
  • Chalmers. Activity-Related Outcomes of Articular Cartilage Surgery: A

Systematic Review. Cartilage. 2013Goyal D. Evidence-based status of microfracture technique: systematic review of Level I and II studies.

  • Arthroscopy. 2013
  • Oussedik S. Treatment of Articular Cartilage Lesions of the Knee by

MFX or ACI: A Systematic Review Arthroscopy. 2015

Half empty

  • r half full?
slide-8
SLIDE 8

Return to Play in the NFL

Mai et al. Am J Sports Med 2016: 44(9)

slide-9
SLIDE 9

Return to Sport & Performance After Microfracture in the Knees

  • f NBA Players

41 NBA Players

Return to sport: 83%

– Length of NBA career following microfracture (4.10 ± 3.91 years) was not sig different from controls.

Harris et al. Orthop J Sports Med 2013: 1(6)

slide-10
SLIDE 10

Prospective Clinical Outcomes Following MFX Surgery For Isolated and Multi-site Defects: Mid-term Follow-up

Weber AE, Locker PL, Tilton A, Cvetanovich GL, Erickson BJ, Yanke AB, Cole BJ

  • 101 knees : 72 had isolated MFX

– Ave age 36, Ave f/u 5.6 yrs

  • Significant and clinically meaningful

improvements

  • Isolated defects and those < 3.6 cm may

be optimal for MFX

AOSSM Toronto 2017

slide-11
SLIDE 11

Failures Osteoarthritis

MFX 32.5% 48% ACI 42.5% 57%

JBJS: 98-A;No.16: 2016 Level 1

  • Differences not sig (p=0.356)

Why not just jump to more sexy options?

slide-12
SLIDE 12

MFX Poor Prognostic Factors:

  • Age > 35-40
  • BMI > 30
  • Size > 4cm2
  • Other than Femoral condyle
  • Duration of symptoms > 12 months
  • Not primary procedure
  • S/P debridement degenerative shoulders
  • <66% fill on MRI
  • Pre-op Tegner <4
slide-13
SLIDE 13

Results after microfracture in different compartments of the knee:

  • Patella the worst

–Deteriorated between 18 and 36 months –Authors advocate

  • ther treatment

methods Kreuz et al. Osteoarthritis and Cartilage 2006

slide-14
SLIDE 14

In search of a single-stage solution

What to do with acute traumatic lesions?

  • Not many single-stage
  • ptions
slide-15
SLIDE 15

Patella Defects >10 yr f/u

J of Knee Surgery 2010: 23(2) Arthroscopy 2013 Oct 29(10)

slide-16
SLIDE 16

Reality: Insurance Challenges

slide-17
SLIDE 17

Microfracture procedure augmented with BioCartilage

  • Standard Microfracture
  • Prepare & apply

Biocartilage

  • Apply Fibrin Glue over

Biocartilage

  • Rehab similar to MFX

But what is “BioCartilage”? And why do it?

slide-18
SLIDE 18

Cartilage Extracellular Matrix: Biocartilage

  • MFX “plus” – augmentation
  • Basic science support
  • Off the shelf availability
  • Awaiting clinical outcome

studies

Chitosan + Blood

slide-19
SLIDE 19

IHC staining for type II collagen

  • What is it?

– Allograft cartilage extracellular matrix (ECM) – Contains key components of cartilage: type II collagen, proteoglycans, and additional cartilaginous growth factors

  • How is it intended to be used?

– Provides a scaffold over microfractured defect – Signals autologous cellular interactions within the scaffold – Goal is to improve the tissue quality formed after utilizing a bone marrow stimulation technique

BioCartilage

Cartilage Extracellular Matrix

Proteoglycan content evidenced by granular matrix (toluidine blue staining)

slide-20
SLIDE 20
  • Processing?

– Cartilage dehydrated then particulated – 100-300 microns – Aseptically packaged – Ambient temp storage – 5 year shelf-life

BioCartilage

Cartilage Extracellular Matrix

slide-21
SLIDE 21

Cartilage Extracellular Matrix

In vivo supportive evidence

Chadha N et al. Porous Cartilage-Derived Matrix Scaffolds for Repair of Articular Cartilage Defects. ORS 2012; Poster No. 0735. Malinin T et al. Induction of regeneration of articular cartilage defects by freeze dried particulate cartilage allografts. ICRS 2009 Meeting; poster presentation.

Baboon model

Control Group Treatment Group

Rabbit Model

slide-22
SLIDE 22

Micronized allograft articular cartilage and PRP improved cartilage repair in this model compared to MFX alone

Am J Sports Med 2016: 44(9)

MFX Defect BioCartilage 2 months

slide-23
SLIDE 23

Single stage option: BioCartilage

31 yo female -Patellar Defect

slide-24
SLIDE 24

BioCartilage Cartilage Extracellular Matrix

  • Single stage MFX augmentation
  • Relatively inexpensive
  • No insurance issues thus far
  • Basic science support
  • Nearly 10,000 cases thus far
  • Awaiting clinical outcome studies
slide-25
SLIDE 25

18 YO Basketball Player with activity related pain and swelling

Courtesy: Tom Carter MD MFC

slide-26
SLIDE 26

18 YO Basketball Player

  • Micronized articular

cartilage allograft

  • Repeat scope for

fibrosis

Courtesy: Tom Carter MD

slide-27
SLIDE 27

MST Rehabilitation

  • Dependent on location,

size, containment

  • CPM, stationary bike
  • Limited WB for 6-8

weeks

– NWB to TTWB

  • Return to sports 5-9

months

slide-28
SLIDE 28

Marrow Stimulation ( + Biocartilage )

is a Viable Option

  • Consider patient & defect factors
  • Simple / Minimal morbidity / Low cost
  • Condylar lesions in young patients do best
  • > 30% Failure rates
  • Fibrocartilage not as durable but may be

good enough for many

  • Risk/Benefit Analysis vs other options
slide-29
SLIDE 29

Micronized Articular Cartilage (BioCartilage)

Can augmentation “MFX plus” improve results?

We hope But, we really don’t know yet…..

slide-30
SLIDE 30

Thank you